10.1007/s00125-016-4046-9 78
Rosi has significant side effects, with some irritation to the gastrointestinal tract, potentially exacerbating gastrointestinal reactions
Moreover, GLP-1 and its analogs have shown positive effects in kidney protection, neuroprotection, and lipid metabolism regulation, and they hold promise in treating conditions like non-alcoholic steatohepatitis (NASH) and Alzheimer's disease
Among adults without diabetes, osteoporosis risk was slightly higher for patients prescribed a GLP-1 than for patients prescribed other weight loss medications, compared to a baseline of stable-weight patients who were prescribed weight loss medications other than a GLP-1
4, genetically proxied BMI, ISI, HDL-C, and TG were significantly associated with an increased risk of MASLD both in the discovery dataset and the replication dataset